Corporate learning platform 360Learning raises $200 million
22 Oct, 2021
– Blue Note Therapeutics announced a $26.25m Series A financing round.
– The round was led by JAZZ Venture Partners and joined by Summer VC.
– Blue Note Therapeutics is dedicated to serving patients suffering from cancer-related distress.
– The capital will also support the development of Blue Note’s pipeline assets.